Skip to main content
Top
Published in: Clinical Research in Cardiology 3/2018

Open Access 01-03-2018 | Critical Perspective

Stratified prevention: opportunities and limitations. Report on the 1st interdisciplinary cardiovascular workshop in Augsburg

Authors: Gregor Kirchhof, Josef Franz Lindner, Stephan Achenbach, Klaus Berger, Stefan Blankenberg, Heiner Fangerau, Henner Gimpel, Ulrich M. Gassner, Jens Kersten, Dorothea Magnus, Herbert Rebscher, Heribert Schunkert, Stephan Rixen, Paulus Kirchhof

Published in: Clinical Research in Cardiology | Issue 3/2018

Login to get access

Abstract

Sufficient exercise and sleep, a balanced diet, moderate alcohol consumption and a good approach to handle stress have been known as lifestyles that protect health and longevity since the Middle Age. This traditional prevention quintet, turned into a sextet by smoking cessation, has been the basis of the “preventive personality” that formed in the twentieth century. Recent analyses of big data sets including genomic and physiological measurements have unleashed novel opportunities to estimate individual health risks with unprecedented accuracy, allowing to target preventive interventions to persons at high risk and at the same time to spare those in whom preventive measures may not be needed or even be harmful. To fully grasp these opportunities for modern preventive medicine, the established healthy life styles require supplementation by stratified prevention. The opportunities of these developments for life and health contrast with justified concerns: A “surveillance society”, able to predict individual behaviour based on big data, threatens individual freedom and jeopardises equality. Social insurance law and the new German Disease Prevention Act (Präventionsgesetz) rightly stress the need for research to underpin stratified prevention which is accessible to all, ethical, effective, and evidence based. An ethical and acceptable development of stratified prevention needs to start with autonomous individuals who control and understand all information pertaining to their health. This creates a mandate for lifelong health education, enabled in an individualised form by digital technology. Stratified prevention furthermore requires the evidence-based development of a new taxonomy of cardiovascular diseases that reflects disease mechanisms. Such interdisciplinary research needs broad support from society and a better use of biosamples and data sets within an updated research governance framework.
Literature
1.
go back to reference Eberbach WH (2014) Personalisierte Prävention: Wirkungen und Auswirkungen. Med R:449 Eberbach WH (2014) Personalisierte Prävention: Wirkungen und Auswirkungen. Med R:449
2.
go back to reference Keil M (2015) Rechtsfragen der individualisierten Medizin. Springer, BerlinCrossRef Keil M (2015) Rechtsfragen der individualisierten Medizin. Springer, BerlinCrossRef
3.
go back to reference Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Lochen ML, Lollgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van derWorp HB, vanDis I, Verschuren WM, Simone B, Document R, DeBacker G, Roffi M, Aboyans V, Bachl N, Bueno H, Carerj S, Cho L, Cox J, DeSutter J, Egidi G, Fisher M, Fitzsimons D, Franco OH, Guenoun M, Jennings C, Jug B, Kirchhof P, Kotseva K, Lip GY, Mach F, Mancia G, Bermudo FM, Mezzani A, Niessner A, Ponikowski P, Rauch B, Ryden L, Stauder A, Turc G, Wiklund O, Windecker S, Zamorano JL (2016) 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur J Prev Cardiol23(11):NP1–NP96 Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Lochen ML, Lollgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van derWorp HB, vanDis I, Verschuren WM, Simone B, Document R, DeBacker G, Roffi M, Aboyans V, Bachl N, Bueno H, Carerj S, Cho L, Cox J, DeSutter J, Egidi G, Fisher M, Fitzsimons D, Franco OH, Guenoun M, Jennings C, Jug B, Kirchhof P, Kotseva K, Lip GY, Mach F, Mancia G, Bermudo FM, Mezzani A, Niessner A, Ponikowski P, Rauch B, Ryden L, Stauder A, Turc G, Wiklund O, Windecker S, Zamorano JL (2016) 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur J Prev Cardiol23(11):NP1–NP96
5.
go back to reference Thaler RH, Sunstein CR (2008) Nudge: improving decisions about health, wealth and happiness. Yale University Press, New Haven Thaler RH, Sunstein CR (2008) Nudge: improving decisions about health, wealth and happiness. Yale University Press, New Haven
6.
go back to reference Leibnitz GW (1671/1672) Directiones ad rem medicam pertinentes. Stud Leibinitiana8:20 und 50 ff Leibnitz GW (1671/1672) Directiones ad rem medicam pertinentes. Stud Leibinitiana8:20 und 50 ff
7.
go back to reference Frank JP. System einer vollständigen medicinischen Policey, pp 1779–1819 Frank JP. System einer vollständigen medicinischen Policey, pp 1779–1819
8.
go back to reference Voegele J. Zur Entwicklung der Gesundheitsverhältnisse im 19. und 20. Jahrhundert. In: SchultzS, SteiglederK, FangerauH, PaulNW (eds) Geschichte, Theorie und Ethik der Medizin. EIne Einfuerung, Frankfurt am Main, p 1006 Voegele J. Zur Entwicklung der Gesundheitsverhältnisse im 19. und 20. Jahrhundert. In: SchultzS, SteiglederK, FangerauH, PaulNW (eds) Geschichte, Theorie und Ethik der Medizin. EIne Einfuerung, Frankfurt am Main, p 1006
9.
go back to reference Lengwiler M, Madarasz J (2010) Das praeventive Selbst. Eine Kulturgeschichte moderner Gesundheitspolotik. Transkript Verlag, BielefeldCrossRef Lengwiler M, Madarasz J (2010) Das praeventive Selbst. Eine Kulturgeschichte moderner Gesundheitspolotik. Transkript Verlag, BielefeldCrossRef
10.
go back to reference Ogah OS, Davison BA, Sliwa K, Mayosi BM, Damasceno A, Sani MU, Mondo C, Dzudie A, Ojji DB, KouamC, Suliman A, Schrueder N, Yonga G, BaS A, Maru F, Alemayehu B, Edwards C, Cotter G (2015) Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: results of the THESUS-HF study. Clin Res Cardiol104(6):481–90CrossRefPubMed Ogah OS, Davison BA, Sliwa K, Mayosi BM, Damasceno A, Sani MU, Mondo C, Dzudie A, Ojji DB, KouamC, Suliman A, Schrueder N, Yonga G, BaS A, Maru F, Alemayehu B, Edwards C, Cotter G (2015) Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: results of the THESUS-HF study. Clin Res Cardiol104(6):481–90CrossRefPubMed
11.
go back to reference Neuzner J (2015) The mismatch between patient life expectancy and the service life of implantable devices in current cardioverter-defibrillator therapy: a call for larger device batteries. Clin Res Cardiol104(6):456–60CrossRefPubMed Neuzner J (2015) The mismatch between patient life expectancy and the service life of implantable devices in current cardioverter-defibrillator therapy: a call for larger device batteries. Clin Res Cardiol104(6):456–60CrossRefPubMed
12.
go back to reference Bunz M, Lenski D, Wedegartner S, Ukena C, Karbach J, Bohm M, Kindermann I (2016) Heart-focused anxiety in patients with chronic heart failure before implantation of an implantable cardioverter defibrillator: baseline findings of the anxiety-CHF study. Clin Res Cardiol105(3):216–224CrossRefPubMed Bunz M, Lenski D, Wedegartner S, Ukena C, Karbach J, Bohm M, Kindermann I (2016) Heart-focused anxiety in patients with chronic heart failure before implantation of an implantable cardioverter defibrillator: baseline findings of the anxiety-CHF study. Clin Res Cardiol105(3):216–224CrossRefPubMed
13.
go back to reference Kobe J, Hucklenbroich K, Geisendorfer N, Bettin M, Frommeyer G, Reinke F, Dechering D, Burgmer M, Eckardt L (2017) Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems. Clin Res Cardiol106(5):317–321CrossRefPubMed Kobe J, Hucklenbroich K, Geisendorfer N, Bettin M, Frommeyer G, Reinke F, Dechering D, Burgmer M, Eckardt L (2017) Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems. Clin Res Cardiol106(5):317–321CrossRefPubMed
14.
go back to reference Christakis NA, Fowler JH (2007) The spread of obesity in a large social network over 32 years. N Engl J Med357(4):370–379CrossRefPubMed Christakis NA, Fowler JH (2007) The spread of obesity in a large social network over 32 years. N Engl J Med357(4):370–379CrossRefPubMed
15.
go back to reference Kirchhof P, Sipido KR, Cowie MR, Eschenhagen T, Fox KA, Katus H, Schroeder S, Schunkert H, Priori S, for the ESC Cardiovascular Round Table and the European Affairs Committee (2014) The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology. Eur Heart J 35(46):3250–3257PubMedPubMedCentral Kirchhof P, Sipido KR, Cowie MR, Eschenhagen T, Fox KA, Katus H, Schroeder S, Schunkert H, Priori S, for the ESC Cardiovascular Round Table and the European Affairs Committee (2014) The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology. Eur Heart J 35(46):3250–3257PubMedPubMedCentral
16.
go back to reference Jackson N, Atar D, Borentain M, Breithardt G, vanEickels M, Endres M, Fraass U, Friede T, Hannachi H, Janmohamed S, Kreuzer J, Landray M, Lautsch D, LeFloch C, Mol P, Naci H, Samani NJ, Svensson A, Thorstensen C, Tijssen J, Vandzhura V, Zalewski A, Kirchhof P (2016) Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology. Eur Heart J 37:747–754 Jackson N, Atar D, Borentain M, Breithardt G, vanEickels M, Endres M, Fraass U, Friede T, Hannachi H, Janmohamed S, Kreuzer J, Landray M, Lautsch D, LeFloch C, Mol P, Naci H, Samani NJ, Svensson A, Thorstensen C, Tijssen J, Vandzhura V, Zalewski A, Kirchhof P (2016) Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology. Eur Heart J 37:747–754
17.
go back to reference Fabritz L, Guasch E, Antoniades C, Bardinet I, Benninger G, Betts TR, Brand E, Breithardt G, Bucklar-Suchankova G, Camm AJ, Cartlidge D, Casadei B, Chua WW, Crijns HJ, Deeks J, Hatem S, Hidden-Lucet F, Kaab S, Maniadakis N, Martin S, Mont L, Reinecke H, Sinner MF, Schotten U, Southwood T, Stoll M, Vardas P, Wakili R, West A, Ziegler A, Kirchhof P (2016) Expert consensus document: defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment. Nat Rev Cardiol13(4):230–237CrossRefPubMed Fabritz L, Guasch E, Antoniades C, Bardinet I, Benninger G, Betts TR, Brand E, Breithardt G, Bucklar-Suchankova G, Camm AJ, Cartlidge D, Casadei B, Chua WW, Crijns HJ, Deeks J, Hatem S, Hidden-Lucet F, Kaab S, Maniadakis N, Martin S, Mont L, Reinecke H, Sinner MF, Schotten U, Southwood T, Stoll M, Vardas P, Wakili R, West A, Ziegler A, Kirchhof P (2016) Expert consensus document: defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment. Nat Rev Cardiol13(4):230–237CrossRefPubMed
18.
go back to reference Martin M, Fangerau H (2015) Technische Medikalisierung in einer alternden Gesellschaft: Instrumentelle Rahmen und normative Folgen am Beispiel präventivmedizinischer Ansätze. In: WeberK, FrommeldD, ManzeschkeA, FangerauH (eds) Technisierung des Alltags Beitrag für ein gutes Leben?Steiner, Stuttgart, pp 15–49 Martin M, Fangerau H (2015) Technische Medikalisierung in einer alternden Gesellschaft: Instrumentelle Rahmen und normative Folgen am Beispiel präventivmedizinischer Ansätze. In: WeberK, FrommeldD, ManzeschkeA, FangerauH (eds) Technisierung des Alltags Beitrag für ein gutes Leben?Steiner, Stuttgart, pp 15–49
Metadata
Title
Stratified prevention: opportunities and limitations. Report on the 1st interdisciplinary cardiovascular workshop in Augsburg
Authors
Gregor Kirchhof
Josef Franz Lindner
Stephan Achenbach
Klaus Berger
Stefan Blankenberg
Heiner Fangerau
Henner Gimpel
Ulrich M. Gassner
Jens Kersten
Dorothea Magnus
Herbert Rebscher
Heribert Schunkert
Stephan Rixen
Paulus Kirchhof
Publication date
01-03-2018
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 3/2018
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-017-1186-y

Other articles of this Issue 3/2018

Clinical Research in Cardiology 3/2018 Go to the issue